Manoj Sharma In The News
Indica News
The world celebrated World Tuberculosis Day on March 24, 2025, with the theme of 鈥淵es, We Can End TB: Commit, Invest, Deliver.鈥 According to the World Health Organization (WHO) in 2023, approximately 10.8 million people were affected by TB globally, including 6.0 million males, 3.6 million women, and 1.3 million children. No country or age group has been spared by TB. According to the Centers for Disease Control and Prevention (CDC), in the United States, 9,633 cases of TB were reported which was an increase of 15.6% over the previous year. It needs to be noted that TB is preventable and curable. Can we eradicate TB like we did smallpox?
IndiaCurrents
Dr. Manoj Sharma, Professor of Social and Behavioral Health and Internal Medicine, answers queries on the 鈥榚mpty nest syndrome鈥.
Indica News
One of the twentieth-century public health achievements that was touted was the prevention of dental caries through fluoridation of water. But the recent political climate has challenged this, and the debate is on. What are the pros and cons of fluoridation of public water?


Indica News
At the end of February 2025, the Centers for Disease Control and Prevention (CDC) reported 164 cases of measles in 9 jurisdictions in Alaska, California, Georgia, Kentucky, New Jersey, New Mexico, New York City, Rhode Island, and Texas. An outbreak of measles is considered when there are 3 or more related cases, and 3 outbreaks have been reported in 2025 with most cases in Texas. A large majority of these cases were unvaccinated individuals and 20% were hospitalized with one confirmed death. This is a cause of alarm for the public as measles was declared to have been eliminated in 2000 in the United States. Hence, we need to be cognizant of precautions and preventive measures.
Indica News
The newer class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic庐) or tirzepatide (Mounjaro庐, Zepbound庐) are gaining popularity all over the world. It is reported that already 2-3% of Americans are taking these drugs. J.P. Morgan Research projects that by 2030, approximately 30 million people, or 9% of the U.S. population may be taking GLP-1 agonists.
India Currents
Dr. Manoj Sharma, a Professor of Social and Behavioral Health and Internal Medicine, answers queries on schizophrenia.